Ezetimibe )ethane-1 2-diamine hydrochloride dual phosphatidylinositol 3-kinase/mammalian target of

dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors

4-tetrahydropyrimidine-5-carboxamide

Raynaud's phenomenon

is a potent and selective IDH2 inhibitor

Pyridostigmine bromide binds reversibly to acetylcholinesterase active sites in the peripheral nervous system

Ezetimibe )ethane-1 2-diamine hydrochloride dual phosphatidylinositol 3-kinase/mammalian target ofEzetimibe, also known as SCH 58235, is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone when other cholesterol lowering medications are not tolerated, or together with statins (e. g., ezetimibe simvastatin) when statins alone do not control cholesterol. Ezetimibe is recommended as second line therapy for those intolerant of statins or unable to achieve target LDL